C20orf4 Inhibitors
Chemical inhibitors of C20orf4 can be understood through their interaction with various cellular signaling pathways that are known to regulate protein function. Staurosporine, a kinase inhibitor, can prevent the phosphorylation that is necessary for the activation of C20orf4 if its function is contingent upon this modification. Similarly, Bisindolylmaleimide I inhibits protein kinase C, which, if C20orf4 is regulated by PKC-mediated phosphorylation, would result in the functional inhibition of C20orf4. LY294002 and Wortmannin both act as PI3K inhibitors and would decrease AKT activation, thereby inhibiting C20orf4 if it is regulated by the PI3K/AKT pathway. Rapamycin, targeting the mTOR pathway, would also suppress C20orf4 function if mTOR signaling is upstream of C20orf4.
Additionally, PD98059 and U0126 target the MEK/ERK pathway, which could inhibit C20orf4 if it relies on this signaling for activity. SB203580 and SP600125 work by inhibiting the p38 MAPK and JNK pathways, respectively. If C20orf4 is modulated by either of these pathways, these inhibitors would diminish its activity. The inhibition of Raf kinase by ZM 336372 would have a similar effect if C20orf4 is regulated by the Raf/MEK/ERK cascade. Y-27632 targets the Rho/ROCK pathway; if C20orf4 is influenced by Rho/ROCK signaling, Y-27632 would lead to reduced C20orf4 activity. Lastly, Gefitinib inhibits EGFR tyrosine kinase and would impair C20orf4 function if it operates downstream of EGFR signaling. Each of these chemicals interacts with specific signaling pathways to inhibit the function of C20orf4, providing a detailed map of potential regulatory mechanisms that control C20orf4 activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit a wide range of kinases. If C20orf4's function relies on phosphorylation by specific kinases, staurosporine could inhibit its function by preventing this phosphorylation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC). If C20orf4 is downstream of PKC signaling or is regulated by PKC-mediated phosphorylation, this compound can inhibit C20orf4 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. If C20orf4 operates within the PI3K/AKT signaling pathway, inhibition of PI3K can reduce AKT activation and consequently C20orf4 function if it is AKT-dependent. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK). If C20orf4's activity is regulated through the MEK/ERK pathway, PD98059 can inhibit its function by blocking this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. C20orf4, if involved in the p38 MAPK pathway, would have reduced activity due to the inhibition of p38 MAPK signaling by this compound. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If C20orf4 functions are modulated by JNK signaling, inhibition by SP600125 could result in functional suppression of C20orf4. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. It functions similarly to LY294002, and if C20orf4 is active in the PI3K/AKT pathway, inhibition of PI3K by Wortmannin would also inhibit C20orf4 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR (mechanistic Target of Rapamycin), which is a part of the PI3K/AKT/mTOR signaling pathway. If C20orf4 is regulated by mTOR, its function would be inhibited by Rapamycin. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
ZM 336372 is a potent and specific inhibitor of Raf kinase. If C20orf4's function is dependent on the Raf/MEK/ERK signaling cascade, this inhibitor would suppress C20orf4 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK (Rho-associated protein kinase). If C20orf4 function is modulated by the Rho/ROCK pathway, inhibition by Y-27632 would lead to a decrease in C20orf4 activity. | ||||||